Quote | Enveric Biosciences Inc Com (NASDAQ:ENVB)
Last: | $0.895 |
---|---|
Change Percent: | -3.33% |
Open: | $0.93 |
Close: | $0.895 |
High: | $0.9448 |
Low: | $0.892 |
Volume: | 45,769 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Enveric Biosciences Inc Com (NASDAQ:ENVB)
2024-04-03 10:00:34 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...
2024-04-03 08:12:40 ET More on Pre-market losers & stocks. Emeren Group Ltd. (SOL) Q4 2023 Earnings Call Transcript Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript Mesoblast Limited 2024 Q2 - Results - Earnings Call Presentation Acorda falls 59%...
Message Board Posts | Enveric Biosciences Inc Com (NASDAQ:ENVB)
Subject | By | Source | When |
---|---|---|---|
Nice flipper | PennyPusher786 | investorshub | 05/18/2023 7:25:40 PM |
Ok it cooled off Five dollar run | Triple nickle | investorshub | 05/18/2023 5:44:17 PM |
Now a Rug Pooool candidate lol... Now it's | PennyPusher786 | investorshub | 05/18/2023 4:42:49 PM |
Another rip or another dump, only the devil knows | PennyPusher786 | investorshub | 05/18/2023 3:53:22 PM |
Good call. Ran to 4.20s and dumped to 3.20s | PennyPusher786 | investorshub | 05/18/2023 3:52:08 PM |
News, Short Squeeze, Breakout and More Instantly...
Enveric Biosciences Inc Com Company Name:
ENVB Stock Symbol:
NASDAQ Market:
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Re...
Product Development Highlights: Selected neuroplastogen lead candidate EB-003, a potential first-in-class therapeutic option for addressing difficult-to-treat mental health disorders by promoting neuroplasticity without inducing hallucinations. Started IND-enabling preclinical activit...